| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Zhi-Dong Ge | Q88269389 |
| P2093 | author name string | Zeljko J Bosnjak | |
| Mingyu Liang | |||
| Anuradha Dhanasekaran | |||
| Xiaowen Bai | |||
| Juan Fang | |||
| Tarun Pant | |||
| P2860 | cites work | LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription. | Q47217934 |
| A G-Rich Motif in the lncRNA Braveheart Interacts with a Zinc-Finger Transcription Factor to Specify the Cardiovascular Lineage. | Q47393528 | ||
| Cardiac apoptosis induced under high glucose condition involves activation of IGF2R signaling in H9c2 cardiomyoblasts and streptozotocin-induced diabetic rat hearts. | Q47404481 | ||
| Expression of the imprinted gene H19 in the human fetus | Q48100844 | ||
| The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy. | Q48382639 | ||
| Functional Classification and Experimental Dissection of Long Noncoding RNAs | Q49649796 | ||
| Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity | Q49960457 | ||
| Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function | Q50187327 | ||
| Long Noncoding RNAs in the Heart: The Regulatory Roadmap of Cardiovascular Development and Disease. | Q50519198 | ||
| Inhibition of the Cardiac Fibroblast-Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction. | Q50935680 | ||
| A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. | Q52241373 | ||
| Targeting LncRNAs in Cardiovascular Disease: Options and Expeditions. | Q52426930 | ||
| Characterization of dysregulated lncRNA-mRNA network based on ceRNA hypothesis to reveal the occurrence and recurrence of myocardial infarction. | Q52659215 | ||
| Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. | Q52682394 | ||
| H19 Induces Abdominal Aortic Aneurysm Development and Progression. | Q52718499 | ||
| Long Noncoding RNA H19 Promotes Osteoblast Differentiation Via TGF-β1/Smad3/HDAC Signaling Pathway by Deriving miR-675. | Q53328056 | ||
| H19 gene expression is up-regulated exclusively by stabilization of the RNA during muscle cell differentiation. | Q53900112 | ||
| Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. | Q54419394 | ||
| The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214. | Q55045459 | ||
| Parental imprinting of the mouse insulin-like growth factor II gene. | Q55052428 | ||
| Type 2 diabetes mellitus | Q58447602 | ||
| Involvement of long noncoding RNA MALAT1 in the pathogenesis of diabetic cardiomyopathy | Q86503405 | ||
| Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats | Q86579540 | ||
| ANRIL: A lncRNA at the CDKN2A/B Locus With Roles in Cancer and Metabolic Disease | Q90827315 | ||
| A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains | Q21266548 | ||
| Parental imprinting of the mouse H19 gene | Q22122365 | ||
| The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation | Q24297656 | ||
| p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest | Q24319021 | ||
| Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a | Q24633736 | ||
| A common allele on chromosome 9 associated with coronary heart disease | Q24647989 | ||
| Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA | Q24655224 | ||
| Genomewide association analysis of coronary artery disease | Q24658344 | ||
| Mechanisms of long noncoding RNA function in development and disease | Q26752329 | ||
| Discovery and functional characterization of cardiovascular long noncoding RNAs | Q26786741 | ||
| Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease | Q26999363 | ||
| Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells | Q28206500 | ||
| Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers | Q28251857 | ||
| A cell cycle regulator potentially involved in genesis of many tumor types | Q28251933 | ||
| Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors | Q28397098 | ||
| H19 acts as a trans regulator of the imprinted gene network controlling growth in mice | Q28505959 | ||
| LIPCAR: a mitochondrial lnc in the noncoding RNA chain? | Q28658644 | ||
| Expression of a single transfected cDNA converts fibroblasts to myoblasts | Q29547764 | ||
| A common variant on chromosome 9p21 affects the risk of myocardial infarction | Q29614954 | ||
| Epigenetic regulation by long noncoding RNAs | Q29618108 | ||
| Role of insulin-like growth factors in embryonic and postnatal growth | Q29620034 | ||
| MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer | Q29620125 | ||
| Diagnostic approaches for diabetic cardiomyopathy. | Q30362092 | ||
| Diabetic cardiomyopathy: pathophysiology and clinical features | Q30457504 | ||
| Identification and initial functional characterization of a human vascular cell-enriched long noncoding RNA. | Q33624033 | ||
| Diabetic cardiomyopathy: where we are and where we are going | Q33690717 | ||
| Epigenetic coordination of embryonic heart transcription by dynamically regulated long noncoding RNAs | Q34082965 | ||
| Nuclear speckles | Q34142111 | ||
| Revealing long noncoding RNA architecture and functions using domain-specific chromatin isolation by RNA purification | Q34247942 | ||
| RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites | Q34253195 | ||
| MALAT1 long non-coding RNA in cancer | Q34496719 | ||
| Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction | Q34576832 | ||
| Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians | Q34790118 | ||
| Updating experimental models of diabetic cardiomyopathy | Q35564129 | ||
| Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development. | Q35646709 | ||
| DECKO: Single-oligo, dual-CRISPR deletion of genomic elements including long non-coding RNAs | Q35817760 | ||
| Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library | Q36178484 | ||
| Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice | Q36467779 | ||
| Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides | Q36532644 | ||
| Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes | Q36592693 | ||
| Diverse and pervasive subcellular distributions for both coding and long noncoding RNAs | Q36661556 | ||
| Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study | Q36724786 | ||
| Systematic Characterization of Long Noncoding RNAs Reveals the Contrasting Coordination of Cis- and Trans-Molecular Regulation in Human Fetal and Adult Hearts. | Q36888921 | ||
| Control of somatic tissue differentiation by the long non-coding RNA TINCR. | Q36907593 | ||
| Cardiomyocyte GTP Cyclohydrolase 1 Protects the Heart Against Diabetic Cardiomyopathy | Q36997215 | ||
| Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options | Q37251297 | ||
| Exploring smooth muscle phenotype and function in a bioreactor model of abdominal aortic aneurysm | Q37356742 | ||
| lncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy | Q37380007 | ||
| Transcription of the non-coding RNA upperhand controls Hand2 expression and heart development | Q37603574 | ||
| Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis | Q37609624 | ||
| Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk | Q37636741 | ||
| MIAT Is a Pro-fibrotic Long Non-coding RNA Governing Cardiac Fibrosis in Post-infarct Myocardium | Q37642709 | ||
| Comprehensive analysis of long non-coding RNAs highlights their spatio-temporal expression patterns and evolutional conservation in Sus scrofa. | Q37663164 | ||
| Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22. | Q37665516 | ||
| Profiling analysis of long non-coding RNAs in early postnatal mouse hearts | Q37684100 | ||
| Exploiting Long Noncoding RNAs as Pharmacological Targets to Modulate Epigenetic Diseases | Q37724407 | ||
| Can the onset of heart failure be delayed by treating diabetic cardiomyopathy? | Q37737932 | ||
| The H19 locus: role of an imprinted non-coding RNA in growth and development. | Q37756737 | ||
| Alternative splicing: a pivotal step between eukaryotic transcription and translation | Q38079475 | ||
| Diabetic cardiomyopathy: from pathophysiology to treatment | Q38253065 | ||
| Long noncoding RNAs in cardiac development and ageing | Q38412337 | ||
| Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes | Q38427211 | ||
| A Long Journey Ahead: Long Non-coding RNAs in Bacterial Infections. | Q38557896 | ||
| Targeting noncoding RNAs in disease | Q38752040 | ||
| Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets? | Q38769281 | ||
| Epigenetic and lncRNA regulation of cardiac pathophysiology | Q38771104 | ||
| Targeting Long Noncoding RNA with Antisense Oligonucleotide Technology as Cancer Therapeutics | Q38807425 | ||
| Long noncoding RNAs in kidney and cardiovascular diseases | Q38824250 | ||
| Linking Long Noncoding RNA Localization and Function | Q38921242 | ||
| New insights into epigenetic modifications in heart failure | Q38998894 | ||
| Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury | Q39095675 | ||
| The Interplay of LncRNA-H19 and Its Binding Partners in Physiological Process and Gastric Carcinogenesis | Q39147883 | ||
| Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure | Q39223911 | ||
| Diabetic Cardiomyopathy: Current Approach and Potential Diagnostic and Therapeutic Targets. | Q39249730 | ||
| Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA. | Q39320927 | ||
| Decoding the Long Noncoding RNA During Cardiac Maturation: A Roadmap for Functional Discovery | Q39426172 | ||
| The oncofetal H19 RNA connection: hypoxia, p53 and cancer | Q39745950 | ||
| Down-regulation of SENCR promotes smooth muscle cells proliferation and migration in db/db mice through up-regulation of FoxO1 and TRPC6. | Q40562195 | ||
| Increased plasma levels of lncRNA H19 and LIPCAR are associated with increased risk of coronary artery disease in a Chinese population | Q41312190 | ||
| lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy | Q41335448 | ||
| Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications | Q41553095 | ||
| Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage | Q42215098 | ||
| LncRNA H19 inhibits autophagy by epigenetically silencing of DIRAS3 in diabetic cardiomyopathy | Q42316210 | ||
| Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes | Q42364924 | ||
| The long noncoding RNA Wisper controls cardiac fibrosis and remodeling | Q42379056 | ||
| Dynamic Organization of lncRNA and Circular RNA Regulators Collectively Controlled Cardiac Differentiation in Humans | Q42577988 | ||
| A large shRNA library approach identifies lncRNA Ntep as an essential regulator of cell proliferation | Q42795715 | ||
| Failure of Isoflurane Cardiac Preconditioning in Obese Type 2 Diabetic Mice Involves Aberrant Regulation of MicroRNA-21, Endothelial Nitric-oxide Synthase, and Mitochondrial Complex I. | Q46201938 | ||
| Spliceosomal protein U1A is involved in alternative splicing and salt stress tolerance in Arabidopsis thaliana | Q46243729 | ||
| CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation | Q46662082 | ||
| Long Noncoding RNAs in Diabetes and Diabetic Complications | Q46667213 | ||
| Long non coding RNA-UCA1 contributes to cardiomyocyte apoptosis by suppression of p27 expression | Q46743970 | ||
| Circulating long non-coding RNAs in plasma of patients with gastric cancer | Q46888178 | ||
| Association of ANRIL Expression with Coronary Artery Disease in Type 2 Diabetic Patients. | Q47199387 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | diabetic cardiomyopathy | Q5270132 |
| long non-coding RNA | Q15087973 | ||
| P304 | page(s) | 197 | |
| P577 | publication date | 2018-10-20 | |
| P1433 | published in | BMC Cardiovascular Disorders | Q15753126 |
| P1476 | title | Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy | |
| P478 | volume | 18 |
| Q90950714 | Genome-wide differential expression profiling of lncRNAs and mRNAs associated with early diabetic cardiomyopathy |
| Q96303794 | Long Noncoding RNA SOX2-OT Exacerbates Hypoxia-Induced Cardiomyocytes Injury by Regulating miR-27a-3p/TGFβR1 Axis |
| Q92659190 | MicroRNAs play an essential role in autophagy regulation in various disease phenotypes |
| Q91940176 | Palbociclib improves cardiac dysfunction in diabetic cardiomyopathy by regulating Rb phosphorylation |
| Q92418301 | Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals |
Search more.